Net Revenue: $3.25 million in Q2 2024, down 8% compared to Q2 2023. Non-Emergency Response Revenue Growth: Increased by 8% year-over-year. Gross Margin: 59%, flat year-over-year, slightly down ...

Asthma is the most common chronic disease of childhood and, in the latter part of the 20th century, reached epidemic proportions. Asthma is generally believed to result from gene-environment ...

If you have asthma, dogs may trigger your symptoms—but not everyone with the disease has the same response to these furry animals. Research suggests that about 33% of people with asthma are also ...

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s ...

INND InnerScope Hearing Technologies, Inc.